Volume 2, Issue 1, February 2014, Page: 1-7
Proportion of Visceral Leishmaniasis and Human Immune Deficiency Virus Co- Infection among Clinically Confirmed Visceral Leishmaniasis Patients at the Endemic Foci of the Amhara National Regional State, North-West Ethiopia
Mulat Yimer, BDU, College of Medicine and Health Sciences,Ethiopia
Bayeh Abera, BDU, College of Medicine and Health Sciences,Ethiopia
Wondemagegn Mulu, BDU, College of Medicine and Health Sciences,Ethiopia
Yohannes Zenebe, BDU, College of Medicine and Health Sciences,Ethiopia
Belay Bezabih, Amhara National Regional Health Bureau, Ethiopia
Received: Sep. 22, 2013;       Published: Dec. 20, 2013
DOI: 10.11648/j.ajbls.20140201.11      View  2711      Downloads  145
Abstract
In East Africa, especially in Ethiopia, the proportion of VL patients with HIV co-infection has increased, despite a decline in the numbers of co-infected patients in Europe. The Metema and Humera lowland areas in the north-west are particularly associated with high HIV co-infection rates, ranging from 18% to 31% of the cases. Therefore, the aim of this study was to determine the proportion of VL/HIV co- infection among clinically confirmed VL patients in the endemic foci of the Amhara Region. Institutional based cross- sectional study was conducted from February to July, 2013 on the proportion of VL/HIV co- infection among clinically confirmed VL patients. For the study, a total of 409 participants who were clinically confirmed VL patients were participated in four selected endemic foci (Libokemkem, Belessa, Metema and west Armachiho). Proportionate allocation was used to determine the number of patients involved in each selected endemic foci. Of the 409 clinically confirmed VL patients, the overall proportion of VL/ HIV co-infection was 74 (18.1%). Among the VL endemic foci, proportion of VL/ HIV co- infection was highest in Abdrafi 69 (93.2%) followed by Metema 5 (6.8 %.). However, in Addis Zemen and Belessa showed nil (0 %). Among the study participants, males were more VL/HIV co-infected 74 (19.4%) than females (0%) (P < 0.012) and the age groups from 21-35 were the highest infected group 68 (16.6%) (P<0. 001). Moreover, those patients who came from rural areas were more VL/ HIV co-infected 46 (35.1%) than urban dwellers 28 (23.1%) (P< 0. 001). Furthermore, daily labourers were the highest infected group 60 (57.1%) (P < 0.001) and those who had no formal education had more VL/HIV co-infected 62 (24.6%) (P < 0.001) than those who had formal education. The overall proportion of VL/ HIV co-infection was still high and among the VL endemic foci, proportion of VL/ HIV co- infection was highest in Abdrafi followed by Metema. However, in Addis Zemen and Belessa showed nil. Therefore, face to face health education is mandatory to create awareness about VL, HIV and VL/HIV co –infection and its consequence at the Kebele level.
Keywords
Visceral Leishmaniasis, Human Immunodeficiency Virus, VL Endemic Foci, Amhara Region
To cite this article
Mulat Yimer, Bayeh Abera, Wondemagegn Mulu, Yohannes Zenebe, Belay Bezabih, Proportion of Visceral Leishmaniasis and Human Immune Deficiency Virus Co- Infection among Clinically Confirmed Visceral Leishmaniasis Patients at the Endemic Foci of the Amhara National Regional State, North-West Ethiopia, American Journal of Biomedical and Life Sciences. Vol. 2, No. 1, 2014, pp. 1-7. doi: 10.11648/j.ajbls.20140201.11
Reference
[1]
Gelanew T, Cruz I, Kuhls K, Alvar J, Canavate C, Hailu A, Schonian G. Multilocus microsatellite typing revealed high genetic variability of Leishmania donovani strains isolated during and after a Kala-azar epidemic in Libo Kemkem district, Northwest Ethiopia. Microb Infec, vol.13, pp. 595-601, 2011.
[2]
Emami MM, Yazdi M. Entomological survey of phlebotomine sandflies (Diptera: Psychodidae) in a focus of visceral leishmaniasis in central Iran. Vect borne Dis, vol. 45, pp.38-43, 2008.
[3]
Andrade BB, Oliveira C I, Brodskyn C I, Barral A, Barral-Netto M. Role of sand fly saliva in human and experimental leishmaniasis: current insights. Scand J Immunol, vol. 66, pp.122–127, 2007.
[4]
Hailu A, Gebre-Michael T, Berhe N, Balkew M. Leishmaniasis in Ethiopia. In: Berhane Y., Hailemariam D. and Kloos H. first eds. The ecology of health and disease in Ethiopia. Addis Ababa: Shaman Books. 2006; pp, 615- 634.
[5]
WHO. Risk factors for Leishmaniasis. Wkly epidemiol record , vol. 44 pp.365-372, 2002.
[6]
Hailu A, Mucciob T D, Abebea T, Hunegnaw M, Kagerd P A, Marina Gramicciab M. Isolation of Leishmania tropica from an Ethiopian cutaneous leishmaniasis patient. Trans Roy Soc Trop Med Hyg, vol.100, pp. 53-58, 2006.
[7]
Alvar J, Bashaye S, Aragaw D, Cruz I, Aparicio P, Kassa A, Orfanos G, Parreno F, Babaniyi O, Gudeta N, Canavate C, Bern C. Kalaazar outbreak in Libokemekm, Ethiopia: epidemiologic and parasitological assessment. Am J Trop Med Hyg, vol. 77, pp. 275-282, 2007.
[8]
Lindtjorn B. Kala-azar in Sidamo, South Ethiopia. Ethiop Med J, vol.18, pp. 99-100, 1980.
[9]
Amahara development agency, Amahara National Regional Health Bureau, 2009
[10]
WHO. Report of the Fifth Consultative Meeting on Leishmania/HIV Co-infection Addis Ababa, Ethiopia, 20–22 March, 2007.
[11]
Mengistu M, Ayele B. Visceral Leishmaniasis and HIV co-infection in patients admitted to Gondar university hospital, northwest Ethiopia. Ethiop J Health Dev, vol. 21(1), pp. 53-60, 2007.
[12]
Alvar J, Aparicio P, Aseffa A. The relationship between leishmaniasis and AIDS: the second 10 years. Clin Microbiol Rev, vol. 21, pp. 334–359, 2008.
[13]
Anema A, Ritmeijer K. Treating HIV/AIDS and leishmaniasis co-infection in Ethiopia. JAMC, vol. 172(11), pp. 1434-1435, 2005.
[14]
Berhe N. Hailu A, Wolday D, Negesse Y, Cenini P, Frommel D. Ethiopian visceral leishmaniasis patients co-infected with human immunodeficiency virus. Trans R Soc Trop Med Hyg, vol. 89, pp. 205-207, 1995.
[15]
Hailu A, Berhe N. The performance of direct agglutination test (DAT) in the diagnosis of visceral leishmaniasis among Ethiopian patients with HIV Co-infection. Ann Trop Med Parasitol, vol. 96(1), pp. 25-30, 2002.
[16]
Ritmeijer K, Veeken H, Melaku Y, Leal G, Amsalu R, Seaman J, Davidson RN. Ethiopian kala-azar: generic sodium stibogluconate and Pentostam are equivalent; HIV co- infected patients have a poor outcome. Trans R Soc Trop Med Hyg , vol. 95(6), pp. 668-672, 2001.
[17]
Federal Democratic Republic of Ethiopia Population Census Commission: Summary and statistical Report of the 2007 Population and Housing Census: Population size by age and sex. Addis Ababa; 2008.
[18]
Bashaye S, Nombela N, Argaw D, Mulugeta A, Herrero M, Nieto J, Chicharro C, Cañavate C, Aparicio P, Darío Vélez I, Alvar J, Bern C. Risk Factors for Visceral Leishmaniasis in a New Epidemic Site in Amhara Region, Ethiopia. Am J Trop Med Hyg, vol. 81 (1), pp. 32-39, 2009.
Browse journals by subject